About Allianz BioInnovation
Allianz BioInnovation is a company based in Mumbai (India) founded in 2015 by Dhaval Mehta. It operates as a B2B. Allianz BioInnovation offers products and services including Molecular Biology Reagents, SARS-CoV-2 Recombinant Protein, Cell Lines, Antibodies, and Custom Services. Allianz BioInnovation operates in a competitive market with competitors including Abcam, Quanterix, Biocare Medical, Merck and BioLife Solutions, among others.
- Headquarter Mumbai, India
- Founders Dhaval Mehta
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sard Biosciences Llp
- Date of Incorporation 23 Jan, 2020
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Allianz BioInnovation
Allianz BioInnovation offers a comprehensive portfolio of products and services, including Molecular Biology Reagents, SARS-CoV-2 Recombinant Protein, Cell Lines, Antibodies, and Custom Services.
Reagents for molecular biology experiments and laboratory use
Proteins for COVID-19 testing and research applications
Cell lines for research and development purposes
Antibodies for diagnostic and analytical applications
Services for molecular biology and outsourcing needs
Funding Insights of Allianz BioInnovation
Detailed funding history for Allianz BioInnovation
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Allianz BioInnovation
Investment portfolio details for Allianz BioInnovation
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Allianz BioInnovation
Detailed financials for Allianz BioInnovation
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Allianz Bioinnovation Comparisons
Peer comparison for Allianz BioInnovation
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Allianz BioInnovation
Allianz BioInnovation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Quanterix, Biocare Medical, Merck and BioLife Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| Locked | Locked | Locked |
Merck is engaged in science and technology solutions globally.
|
|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
Detailed competitors of Allianz BioInnovation
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Allianz Bioinnovation
Complete news archive for Allianz BioInnovation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Allianz BioInnovation
Allianz BioInnovation was founded in 2015.
Allianz BioInnovation is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Allianz Bioinnovation is a biotechnology company based in Mumbai, India, offering research products like molecular biology reagents, cell lines, and recombinant proteins. It provides diagnostic tools for vaccine development and COVID-19 testing, along with custom services for laboratories. The company serves clients in healthcare and research sectors through direct sales and support.
Allianz BioInnovation's top competitors include Abcam, Biocare Medical and Sino Biological.
Allianz BioInnovation offers Molecular Biology Reagents, SARS-CoV-2 Recombinant Protein, Cell Lines, Antibodies, and Custom Services.